13F filing recap · Q2 2013

What did ValueAct Capital buy in Q2 2013?

Reported stock-position changes between this filing and the previous one.

Stock value

$9.74B

Positions

Estimated turnover

19.8%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

CFCf Industries Holdings, Inc.$171.50Mreported value+1.00M shares TECHBio-Techne Corp$4.28Mreported value+62.0K shares

Increased positions

MSFTMicrosoft Corporation$1.99Breported value+24.40M shares+73.1%VRXValeant Pharmaceuticals International, Inc.$1.63Breported value+1.36M shares+7.8%CBRECbre Group, Inc.$747.55Mreported value+1.5K shares+0.0%WTWWillis Towers Watson Plc$742.79Mreported value+1.71M shares

Reduced positions

BCRC.r. Bard, Inc.$82.46Mreported value-2.86M shares-79.0%GDIGardner Denver Holdings Inc$48.37Mreported value-1.86M shares-74.3%

Exited positions

MHFIS&P Global Inc.$76.17Mprior reported value-1.46M shares-100.0%ALBAlbemarle Corporation$59.78Mprior reported value-956.2K shares-100.0%TIBXTibco Software Inc$7.85Mprior reported value-388.1K shares-100.0%